Beckman Coulter Genomics' BRAF Assay Receives State Licensures | GenomeWeb

NEW YORK (GenomeWeb News) – Beckman Coulter Genomics today said that three states have licensed its BRAF assay, expanding the availability of the test.

Pennsylvania, Maryland, and Rhode Island have granted clinical laboratory licenses to Beckman Coulter Genomics for the assay, which is CLIA certified. Massachusetts licensed the assay last year, and of the seven states that require licensures in addition to CLIA certification for certain tests to be offered there, Florida, California, and New York remain the only ones that have not licensed Beckman Coulter's BRAF assay.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.